“Hurdles on the path to 90-90-90 and beyond”: Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat

Background Despite substantial progress, gaps in the HIV care cascade remain large: globally, while about 36.7 million people were living with HIV in 2015, 11.9 million of these individuals did not know their HIV status, 12.7 million were in need of antiretroviral therapy (ART) and 13.0 million were not virally suppressed. We sought to deepen understanding of the barriers to care engagement at three critical steps of the care cascade proposed to make greatest impact for attaining the UNAIDS 90-90-90 targets aimed at shutting down the HIV epidemic. Methods Analyses were conducted among HIV-infected adults in rural East Africa. Qualitative data were collected using in-depth interviews among 63 individuals participating in an ongoing test-and treat trial (NCT01864683) in its baseline year (July 2013-June 2014). Audio recordings were transcribed, translated into English, and coded using Atlas.ti software. Data were analyzed using a thematic framework for explaining barriers to care engagement that drew upon both theory and prior empirical research in similar settings. Results Multiple barriers to engagement in care were observed. HIV-related stigma across dimensions of anticipated, internalized and enacted stigma manifested in denial and fears of disclosure, and influenced lapses in care engagement across multiple steps in the cascade. Poverty (lack of food and transport), lack of social support, work interference, prior negative experiences with health services, drug side effects, and treatment fatigue also negatively affected ART adherence and viral suppression. Gender differences were observed, with work interference and denial disproportionately affecting men compared to women. Conclusion Multiple barriers to HIV care engagement still pervade rural sub-Saharan settings threatening the realization of the UNAIDS 90-90-90 targets. To control the epidemic, efforts need to be accelerated to combat stigma. Patient economic empowerment, innovative drug formulations, as well as more patient-responsive health systems, may help overcome barriers to engagement in care.

[1]  M. Petersen,et al.  High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya , 2017, Journal of the International AIDS Society.

[2]  J. Gallant,et al.  Antiretroviral Therapy for the Prevention of HIV-1 Transmission. , 2016, The New England journal of medicine.

[3]  M. Petersen,et al.  “How can I tell?” Consequences of HIV status disclosure among couples in eastern African communities in the context of an ongoing HIV “test-and-treat” trial , 2016, AIDS care.

[4]  M. Petersen,et al.  A hybrid mobile HIV testing approach for population-wide HIV testing in rural East Africa: an observational study , 2016, The lancet. HIV.

[5]  J. Kelly,et al.  Barriers and Facilitators of HIV Care Engagement: Results of a Qualitative Study in St. Petersburg, Russia , 2016, AIDS and Behavior.

[6]  D. Glidden,et al.  Patient-reported factors associated with reengagement among HIV-infected patients disengaged from care in East Africa , 2015, AIDS.

[7]  K. Glanz,et al.  Barriers and facilitators to patient retention in HIV care , 2015, BMC Infectious Diseases.

[8]  Kenneth H Mayer,et al.  Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial. , 2014, The Lancet. Infectious diseases.

[9]  James J. Goedert,et al.  Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada , 2013, PloS one.

[10]  Stefan Baral,et al.  A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? , 2013, Journal of the International AIDS Society.

[11]  T. Hart,et al.  Protective and risk factors associated with stigma in a population of older adults living with HIV in Ontario, Canada , 2013, AIDS care.

[12]  S. Kaaya,et al.  Toward an Understanding of Disengagement from HIV Treatment and Care in Sub-Saharan Africa: A Qualitative Study , 2013, PLoS medicine.

[13]  S. Karim,et al.  Antiretroviral prophylaxis: a defining moment in HIV control , 2011, The Lancet.

[14]  Lei Wang,et al.  Prevention of HIV-1 infection with early antiretroviral therapy. , 2011, The New England journal of medicine.

[15]  J. Nachega,et al.  Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs , 2011, Patient preference and adherence.

[16]  Connie Celum,et al.  Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis , 2010, The Lancet.

[17]  E. Vittinghoff,et al.  Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco , 2010, PloS one.

[18]  J. Parsons,et al.  Loneliness and HIV-related stigma explain depression among older HIV-positive adults , 2010, AIDS care.

[19]  Matthias Egger,et al.  Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis , 2009, AIDS.

[20]  A. Fauci,et al.  Universal voluntary testing and treatment for prevention of HIV transmission. , 2009, JAMA.

[21]  C. Logie,et al.  Meta-analysis of health and demographic correlates of stigma towards people living with HIV , 2009, AIDS care.

[22]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[23]  J. Bradford The promise of outreach for engaging and retaining out-of-care persons in HIV medical care. , 2007, AIDS patient care and STDs.

[24]  J. Bradford,et al.  Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. , 2007, AIDS patient care and STDs.

[25]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[26]  L. Spencer,et al.  Qualitative data analysis for applied policy research , 2002 .

[27]  Keith F Widaman,et al.  HIV-related stigma and knowledge in the United States: prevalence and trends, 1991-1999. , 2002, American journal of public health.

[28]  E. Goffman Stigma; Notes On The Management Of Spoiled Identity , 1964 .

[29]  Sarah Mae Sincero,et al.  Ecological systems theory , 2020, Zbornik radova Filozofskog fakulteta u Splitu.

[30]  Gundo Weiler,et al.  Global Update on HIV Treatment 2013: Results, Impact and Opportunities , 2013 .

[31]  Maria Jirwe,et al.  Analysing qualitative data. , 2011, Nurse researcher.

[32]  P. Harrigan,et al.  Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  P. Aggleton,et al.  HIV/AIDS-related Stigma and Discrimination: A Conceptual Framework and Agenda for Action , 2002 .